trending Market Intelligence /marketintelligence/en/news-insights/trending/kQVecVPvF9twH695028qyg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Ampio to sell common stock, warrants in registered direct offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Ampio to sell common stock, warrants in registered direct offering

Ampio Pharmaceuticals Inc. agreed to sell to investors about $6.3 million of common stock and accompanying share purchase warrants at 60 cents apiece in a registered direct offering.

The warrants are exercisable for 76 cents per share, six months after issuance and have a term of five years from the issuance date.

Closing of the offering is expected to occur June 7, subject to customary closing conditions.

Ampio plans to use the net proceeds for working capital and general corporate purposes, including financing of its Ampion clinical trial.

Joseph Gunnar & Co. LLC and Fordham Financial Management Inc. are acting as placement agents for the offering.